Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.

doi:10.1089/gte.1999.3.3

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.

Genetic testing - 1 Jan 1999

McConnell L M, Koenig B A, Greely H T, Raffin T A

Abstract excerpt

Several genes associated with Alzheimer disease (AD) have been localized and cloned; two genetic tests are already commercially available, and new tests are being developed. Genetic testing for AD--either for disease prediction or for diagnosis--raises critical ethical concerns. The multidisciplinary Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics, and Society (PGES) presents...

Topics

Alzheimer Disease
Ethics, Medical
Genetic Predisposition to Disease
Genetic Testing
Humans

Source

Open in PubMed

Identifiers

PMID: 10464572
DOI: 10.1089/gte.1999.3.3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics